Who Paid My Doc
Kymriah
Drug Oncology
NDC 0078-0846-19
General payments
$329,825
Research payments
$12,501,967
Through program year 2025, $329,825 in general payments and $12,501,967 in research payments were reported against Kymriah (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $143,655 | 441 |
| 2025 | Research | $2,616,731 | 270 |
| 2024 | General | $96,123 | 371 |
| 2024 | Research | $6,192,789 | 210 |
| 2023 | General | $90,048 | 332 |
| 2023 | Research | $3,692,447 | 310 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 33 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,144 general · 790 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.